SCHEDULE 13G/A

CONNECT BIOPHARMA HLDGS LTD

Ordinary shares, par value US$0.000174 per share · CUSIP: G23549101

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Qiming Managing Directors Fund V, L.P.

  Shares: 54,826.00 · Class: 0.1%

• Qiming Venture Partners V, L.P.

  Shares: 1,766,600.00 · Class: 2.8%

• Qiming Corporate GP V, Ltd.

  Shares: 1,821,426.00 · Class: 2.9%

• Qiming GP V, L.P.

  Shares: 1,766,600.00 · Class: 2.8%

• Qiming GP VII, LLC

  Shares: 935,064.00 · Class: 1.5%

• Qiming Venture Partners VII, L.P.

  Shares: 926,527.00 · Class: 1.5%

• Qiming VII Strategic Investors Fund, L.P.

  Shares: 8,537.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.